Evidence map›Paper›PMID 32090492›Full record

Trial reportAndrology2020

Therapeutic use of pulsed electromagnetic field therapy reduces prostate volume and lower urinary tract symptoms in benign prostatic hyperplasia.

Marta Tenuta, Maria G Tarsitano, Paola Mazzotta, Livia Lucchini, Franz Sesti, Giorgio Fattorini, Carlotta Pozza, Valerio Olivieri, Fabio Naro, Daniele Gianfrilli and 3 more

Open access · hybridAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Andrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Marta TenutaDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.ORCID 0000-0002-7476-0737
Maria G TarsitanoDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Paola MazzottaDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Livia LucchiniDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Franz SestiDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Giorgio FattoriniDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Carlotta PozzaDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Valerio OlivieriDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Fabio NaroDepartment of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, Rome, Italy.
Daniele GianfrilliDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.ORCID 0000-0002-2682-8266
Andrea LenziDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Andrea M IsidoriDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.ORCID 0000-0002-9037-5417
Riccardo PofiDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.ORCID 0000-0001-7808-5735
Sapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBenign prostatic hyperplasia (BPH) etiology remains poorly understood, but chronic low-grade inflammation plays a role. Pulsed electromagnetic field therapy (PEMF) (1-50 Hz) is effective in reducing tissue inflammation.

objectivesWe designed a pilot study to evaluate the effects of PEMF on prostate volume (PV) in BPH. MATERIALS AND

methodsThis is a prospective interventional trial on 27 naive patients with BPH and lower urinary tract symptoms (LUTS). At baseline (V

resultsA reduction was observed both at V DISCUSSION: PEMF was able to reduce PV after 28 days of therapy. Symptoms improved in a short time, with high compliance and no effects on hormonal and sexual function or any side effects. Patients with moderate-severe LUTS and without MetS seem to benefit more from this treatment.

conclusionPEMF reduces PV and improves LUTS in a relative short time, in BPH patients. These benefits seem greater in those patients with moderate-severe LUTS but without MetS.

Indexed as

Magnetic Field TherapyAgedHumansMaleMiddle AgedOrgan SizePilot ProjectsProspective StudiesProstateProstatic HyperplasiaProstatismSurveys and QuestionnairesTreatment OutcomeBPHinflammationIPSSLUTSPEMFprostate volume

Identifiers

PMID32090492
PMCPMC7496682
OpenAlexW3008930481

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.